Hollings Clinical Trials is a medical research database for cancer patients and providers at the Medical University of South Carolina, available on iOS.
The App DNA
What makes this app unique?
The app replaces fragmented institutional search processes with a unified mobile interface, reducing the cognitive load for patients seeking specific cancer treatment trials.
For Patients, caregivers, healthcare providers, and research staff seeking information on cancer clinical trials at the MUSC Hollings Cancer Center.
What does it look like?
Key features
Filterable database of cancer treatment, prevention, and supportive oncology trials organized by disease group.
Restricted access to protocols and informed consent forms for employees with a MUSC Net ID.
In-app form to request assistance from the Hollings Cancer Center Clinical Trials Office.
How much does it cost?
The app is a free institutional tool provided by the Medical University of South Carolina to support clinical trial recruitment.
Velocity
Maintenance developmentUX improvementsShow more...
Hollings Clinical Trials maintains a low-frequency release cadence, with only one update shipped in the last 23 days. Development activity is currently limited, focusing on interface refinements rather than frequent feature iteration. Given the current pace, the app operates in a maintenance state, providing infrequent updates to its core clinical trial interface.
Who built it?
The Medical University of South Carolina
3 apps tracked · Medical
Tobi app
MUSC CHP Self-Guided TourUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Hollings Clinical Trials
How's the Medical market?
Hollings Clinical Trials functions as a specialized institutional utility, holding a 5-star rating on the App Store based on early user feedback. Its position is defined by its exclusive integration with MUSC research programs, which serves as a recruitment funnel for the Hollings Cancer Center.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Hollings Clinical Trials
Where is it heading?
The outlook for institutional medical tools remains stable, as these platforms serve specific, high-intent user groups rather than broad consumer markets. Hollings Clinical Trials will likely continue to function as a specialized recruitment funnel, with success measured by trial enrollment volume rather than active user counts.
- The latest release introduced a redesigned user interface, signaling that the app remains in active maintenance rather than sunset mode.
- Institutional backing from the Medical University of South Carolina ensures long-term support, insulating the app from the churn risks facing independent health aggregators.
The SWOT
- Institutional integration with MUSC research protocols provides a defensible barrier to entry.
- Expansion of patient-facing educational content could increase engagement beyond the initial search phase.
Next best moves
Audit search filter logic because users report difficulty identifying relevant studies → increase trial enrollment conversion.
The counter-intuitive read
The app's low update frequency is a feature, not a bug…
Read the full takeBottom line
Hollings Clinical Trials functions as a stable recruitment utility, and its value depends on the accuracy of its trial database rather than feature expansion.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated